Pancreatic Cancer Research

ResearcherErasmus MCActive in the last 2 years

Jelle C. van Dongen

Matched on ORCID iD 0000-0003-2505-0066; OpenAlex author ID A5088430138. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2022: 3 papers · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers

Papers 8

  1. Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationwide prospective cohort study. First author DOI 10.1016/j.ejca.2025.116065↗
  2. Delayed gastric emptying after pancreatic cancer surgery impacts time to start of adjuvant treatment but not overall survival: a post-hoc analysis of the PREOP… Co-author DOI 10.1093/bjs/znaf261↗
  3. Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancrea… Co-author DOI 10.1016/j.surg.2024.01.029↗
  4. The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial. Co-author DOI 10.1016/j.ejso.2022.12.011↗
  5. Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, obs… First author DOI 10.1093/bjsopen/zrac174↗
  6. Age and prognosis in patients with pancreatic cancer: a population-based study. Co-author DOI 10.1080/0284186x.2021.2016949↗
  7. Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderl… Co-author DOI 10.1097/sla.0000000000004313↗
  8. High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma. First author DOI 10.3389/fonc.2022.827755↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bas Groot Koerkamp · 7 shared papers, 2022–2025 · strength 1.04
  2. Casper H.J. van Eijck · 7 shared papers, 2022–2025 · strength 1.04
  3. Ignace H. J. T. de Hingh · 5 shared papers, 2022–2025 · strength 0.75
  4. Marc G. Besselink · 5 shared papers, 2022–2024 · strength 0.71
  5. Judith de Vos‐Geelen · 4 shared papers, 2022–2025 · strength 0.64
  6. Vincent Erwin de Meijer · 4 shared papers, 2022–2024 · strength 0.58
  7. Gijs A. Patijn · 4 shared papers, 2022–2024 · strength 0.55
  8. Sebastiaan Festen · 4 shared papers, 2022–2024 · strength 0.55
  9. Bert A. Bonsing · 4 shared papers, 2022–2024 · strength 0.55
  10. Johanna W. Wilmink · 3 shared papers, 2022–2025 · strength 0.51
  11. Hjalmar C. van Santvoort · 3 shared papers, 2022–2024 · strength 0.44
  12. Geertjan van Tienhoven · 3 shared papers, 2022–2024 · strength 0.42
  13. Mustafa Suker · 3 shared papers, 2022–2023 · strength 0.40
  14. J. Sven D. Mieog · 3 shared papers, 2022–2023 · strength 0.40
  15. Izaak Quintus Molenaar · 2 shared papers, 2023–2024 · strength 0.29
  16. Marion B.M. van der Kolk · 2 shared papers, 2023 · strength 0.27
  17. Eva Versteijne · 2 shared papers, 2022–2023 · strength 0.27
  18. Willem de Koning · 1 shared paper, 2025 · strength 0.20
  19. Michail Doukas · 1 shared paper, 2025 · strength 0.20
  20. Nigel G. Kooreman · 1 shared paper, 2025 · strength 0.20
  21. Gaby J. Strijk · 1 shared paper, 2025 · strength 0.20
  22. Marjolein Y.V. Homs · 1 shared paper, 2025 · strength 0.20
  23. Lodewijk A.A. Brosens · 1 shared paper, 2025 · strength 0.20
  24. Lydia G. van der Geest · 1 shared paper, 2022 · strength 0.16
  25. Martijn Intven · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.